Supplements and Featured Publications
Abriendo Puertas a los Profesionales con el Multimodal Maestro2
The Only Branded Steroid Indicated for Inflammation Associated with a Range of Ocular Surface Conditions
A Reliable Treatment for Blepharitis/Meibomian Gland Dysfunction, with Increased Ocular Bioavailability
Glaucoma 360: Highlights from 2021
Glaucoma 360: Highlights from 2020
Advertisement
Advertisement
Trending on Ophthalmology Times - Clinical Insights for Eye Specialists
1
DSLT for glaucoma and ocular hypertension: Real-world outcomes in 218 eyes
2
NCX 470 gains positive regulatory feedback in China ahead of US NDA submission
3
Label Updates and Dosing Flexibility in Retinal Vascular Diseases
4
First patient dosed in phase 3 pivotal cohort of LIGHTHOUSE trial evaluating ATSN-201 for X-linked retinoschisis
5